Have racial disparities in ovarian cancer increased over time? An analysis of SEER data (Q34080488)

30 July 2017

Have racial disparities in ovarian cancer increased over time? An analysis of SEER data (English)

1 reference

30 July 2017

1 reference

1

Mishka Terplan

1 reference

30 July 2017

Nicholas Schluterman

2

1 reference

30 July 2017

Erica J McNamara

series ordinal

3

1 reference

30 July 2017

J Kathleen Tracy

series ordinal

4

1 reference

30 July 2017

Sarah M Temkin

series ordinal

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

21 November 2011

1 reference

30 July 2017

1 reference

30 July 2017

125

1 reference

30 July 2017

1

1 reference

30 July 2017

19-24

1 reference

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Ethnic differences in survival among women with ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Racial disparities affecting the reproductive health of African-American women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Racial disparities in ovarian cancer surgical care: a population-based analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Race in ovarian cancer treatment and survival: a systematic review with meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

10.1016/J.YGYNO.2011.11.025

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference